Deer, Timothy R.
Naidu, Ramana
Strand, Natalie
Sparks, Dawn
Abd-Elsayed, Alaa
Kalia, Hemant
Hah, Jennifer M.
Mehta, Pankaj
Sayed, Dawood
Gulati, Amitabh
Article History
Received: 23 December 2019
Accepted: 24 March 2020
First Online: 24 April 2020
Ethics approval and consent to participate
: The manuscript is a review article and this is not applicable.
: All authors consent to publication as an original article.
: TRD: consultant for Axonics, Abbott, Nalu, Saluda, Medtronic, Nevro, Boston Scientific (Vertiflex), Vertos, Cornerloc, SPR Therapeutics, Flowonix. Stimgenics.RKN: Consultant for Abbott, Avanos, Bicycle Health, Boston Scientific, CereVu, ExerAI, KarunaVR, Nalu, Omnia Medical, Sonosite, SPR Therapeutics, Vertiflex, Vertos.NHS: nothing to declare.DS: nothing to declare.AA: consultant for Medtronic, StimWave, Avanos and Sollis.JMH: Nothing to declare.HK: nothing to declare.PM: Consultant for Abbott, CornerLoc SPR Therapeutics, Vertiflex, Ethos Labs.DS: Abbott, Flowonix, Medtronic, Nevro, PainTeq, SPR, Stimgenics, Vertos, Vertiflex.AG: Consultant for Medtronic, Flowonix, AIS, SPR Therapeutics, Nalu, EnsoRelief.